The FDA's new oversight rules for AI and wearables aren't about safety—they're about control. Unpacking who truly benefits from this regulatory shift.
The FDA's Digital Health COE isn't just about innovation; it's a quiet power play shaping the future of digital health regulation.
The official warning against using AI chatbots for mental health support hides a deeper crisis: the failure of human infrastructure.
The FDA's Digital Health Center of Excellence sounds benign, but it signals a massive, unaddressed shift in **digital health regulation** and **telemedicine adoption**.